Keyphrases
Netherlands
100%
Low Risk
100%
Cost-utility Analysis
100%
Transcatheter Aortic Valve Implantation
100%
Severe Aortic Stenosis
100%
Surgical Mortality
100%
Surgical Aortic Valve Replacement
80%
Dutch
20%
Sensitivity Analysis
20%
Quality-adjusted Life Years
20%
Cost Data
20%
SAPIEN 3
20%
High Risk
10%
Adverse Events
10%
Clinical Benefit
10%
Patient Demographics
10%
Cost-effectiveness
10%
Markov Model
10%
Cost-utility
10%
Intermediate Risk
10%
Patient Outcomes
10%
Low-risk Patients
10%
Cost Outcomes
10%
Incremental Cost-effectiveness Ratio
10%
Utility Model
10%
Life-years Gained
10%
Probabilistic Sensitivity Analysis
10%
Dutch Healthcare System
10%
Cost Implications
10%
Societal Benefits
10%
Health Economic Model
10%
Low-risk Population
10%
Intervention Selection
10%
Lifetime Healthcare Costs
10%
Low-risk Trials
10%
Specific Cost
10%
INIS
patients
100%
surgery
100%
valves
100%
mortality
100%
risks
100%
comparative evaluations
100%
cost
100%
netherlands
100%
utilities
100%
data
16%
interventions
16%
sensitivity analysis
16%
populations
11%
lifetime
11%
datasets
5%
markov process
5%
economics
5%
probabilistic estimation
5%
Nursing and Health Professions
Cost Utility Analysis
100%
Surgical Mortality
100%
Transcatheter Aortic Valve Implantation
100%
Aortic Stenosis
100%
Aortic Valve Replacement
80%
Quality Adjusted Life Year
20%
Adverse Event
10%
Healthcare System
10%
Cost Effectiveness Analysis
10%
Health Care Cost
10%
Treatment Outcome
10%
Incremental Cost-Effectiveness Ratio
10%
Health Economics
10%
Patient Population
10%
Low Risk Population
10%
Medicine and Dentistry
Health Care Cost
100%
Surgical Mortality
100%
Aortic Stenosis
100%
Percutaneous Aortic Valve Replacement
100%
Aortic Valve Replacement
63%
Cost-Effectiveness Analysis
18%
Quality Adjusted Life Year
18%
Lifespan
18%
Adverse Event
9%
Patient Population
9%
Low Risk Population
9%
Pharmacology, Toxicology and Pharmaceutical Science
Surgical Mortality
100%
Aortic Stenosis
100%
Adverse Event
25%